According to Cryo-Cell's latest financial reports the company has a price-to-book ratio of -7.00.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | N/A | -100% |
2023-12-31 | -4.32 | -81.73% |
2022-12-31 | -23.6 | -199.98% |
2021-12-31 | 23.6 | -208.47% |
2020-12-31 | -21.8 | 183.04% |
2019-12-31 | -7.70 | 17.28% |
2018-12-31 | -6.57 | 19.56% |
2017-12-31 | -5.49 | 173.5% |
2016-12-31 | -2.01 | -65.42% |
2015-12-31 | -5.81 | 162% |
2014-12-31 | -2.22 | 3.38% |
2013-12-31 | -2.14 | -16.98% |
2012-12-31 | -2.58 | -73.19% |
2011-12-31 | -9.64 | -65.78% |
2010-12-31 | -28.2 | 597.29% |
2009-12-31 | -4.04 | 459.18% |
2008-12-31 | -0.7221 | -48.39% |
2007-12-31 | -1.40 | -88.96% |
2006-12-31 | -12.7 | -112.65% |
2005-12-31 | 100 | -271.09% |
2004-12-31 | -58.6 | 2302.71% |
2003-12-31 | -2.44 | -148.88% |
2002-12-31 | 4.99 |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Omnicell
OMCL | 1.16 | -116.62% | ๐บ๐ธ USA |
Global Cord Blood CORBF | 0.2175 | -103.11% | ๐ญ๐ฐ Hong Kong |
CorVel Corporation
CRVL | 17.8 | -353.57% | ๐บ๐ธ USA |